Literature DB >> 14636749

Evaluation of donor skin viability: fresh and cryopreserved skin using tetrazolioum salt assay.

Carlotta Castagnoli1, Daniela Alotto, Irene Cambieri, Raffaella Casimiri, Matteo Aluffi, Maurizio Stella, Simone Teich Alasia, Gilberto Magliacani.   

Abstract

Cell viability assessment in allograft skin is an essential step to ensure a supply of good quality allograft skin for clinical repair of wounds. It is widely recognised that 'take' of allografts is strongly influenced grafted by tissue viability. The aim of this study was to set-up storage protocols that maintain high viability of the allograft after harvest, treatment and storage. In this study, the viability of post-mortem allografts (n=350) harvested from 35 different donors, was investigated using the MTT salt assay. The conditions of preparation and storage of the allograft included: 1. Fresh skin samples (about 12, 30, and 60h after harvesting). 2. The same specimens (stored at 4 and 37 degrees C) tested for at least 1 month. 3. Samples after cryopreservation and thawing. 4. Thawed specimens tested daily for at least 6 days. Parallel histomorphological analysis performed, under each of these conditions, showed a correlation between changes in structure and changes in viability as measured by the MTT quantitative assay. The viability index (VI) of skin is expressed as the ratio between the optical density (O.D.) produced in the MTT assay by the skin sample and its weight in grams. The percentage viability index is the ratio of the VI of the fresh sample (considered as 100% viability) and the value of specimens from the same harvest batch after storage or cryopreservation. The results indicated that samples tested within 12-30h from harvesting have an average viability index of about 75 with little variation. Samples tested within 60h have an average viability index of 40, showing a viability decrease of about 50%. A protocol to treat skin within a maximum of 30h was, therefore, set-up. The data suggested that skin stored at 37 degrees C, undergoes a viability increase during the first 2 days after harvesting. However, the viability under these conditions then decreased very quickly. After 6 days of preservation at this temperature the samples were no longer viable (PVI = 0). The tissue structure started to become damaged after 3 days. On the other hand, skin stored at 4 degrees C, showed a very slow viability decrease. After 15 days, viability was still almost 25% of the fresh sample. The tissue architecture showed no signs of damage under these conditions until day 7 from harvesting. MTT analysis was performed on the specimens cryopreserved with DMSO at 10%. These measurements were compared to viability assessment of the same fresh skin samples (considered as 100%) that were analysed within 30h from harvesting. The average PVI of thawed skin was 54% of the fresh sample. This result demonstrates that the viability of cryopreserved skin is comparable to the viability of fresh skin stored at 4 degrees C for 4 days. The PVI of thawed skin samples decreased dramatically within 24h, and had reached 0% within 6 days.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636749     DOI: 10.1016/j.burns.2003.01.001

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  22 in total

1.  Cryopreservation with glycerol improves the in vitro biomechanical characteristics of human patellar tendon allografts.

Authors:  Lovro Suhodolčan; Miha Brojan; Franc Kosel; Matej Drobnič; Armin Alibegović; Janez Brecelj
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-15       Impact factor: 4.342

Review 2.  State of the art in burn treatment.

Authors:  Bishara S Atiyeh; S William Gunn; Shady N Hayek
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

3.  The use of banked skin in the Burns Centre of Verona.

Authors:  Federica Bosco; Maurizio Governa; Leonardo Rossati; Enrico Vigato; Aurora Vassanelli; Giuseppe Aprili; Massimo Franchini
Journal:  Blood Transfus       Date:  2011-01-17       Impact factor: 3.443

4.  Clinical Impact of Cryopreservation on Split Thickness Skin Grafts in the Porcine Model.

Authors:  Paul W Holzer; Alexandre G Lellouch; Krysta Moulton; Laurence Zhu; Zhi Yang Ng; Bo Overschmidt; Amon-Ra Gama; Angelo A Leto Barone; Ivy Rosales; Rod Monroy; Curtis L Cetrulo
Journal:  J Burn Care Res       Date:  2020-02-19       Impact factor: 1.845

5.  Epi/perineural and Schwann Cells as Well as Perineural Sheath Integrity are Affected Following 2,4-D Exposure.

Authors:  Marzieh Sharifi Pasandi; Farshad Hosseini Shirazi; Mohammad Reza Gholami; Hossein Salehi; Nowruz Najafzadeh; Mohammad Mazani; Hatef Ghasemi Hamidabadi; Ali Niapour
Journal:  Neurotox Res       Date:  2017-07-11       Impact factor: 3.911

6.  Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.

Authors:  Anthony P Cardile; Ronald L Woodbury; Carlos J Sanchez; Sandra C Becerra; Rebecca A Garcia; Katrin Mende; Joseph C Wenke; Kevin S Akers
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Utility of cell viability assays for use with ex vivo vocal fold epithelial tissue.

Authors:  Elizabeth Erickson-DiRenzo; M Preeti Sivasankar; Susan L Thibeault
Journal:  Laryngoscope       Date:  2014-12-15       Impact factor: 3.325

8.  Cryopreservation of composite tissue transplants.

Authors:  Brian Rinker; Xiangdong D Cui; Michael L Cibull; Betsy F Fink; Dayong Y Gao; Henry C Vasconez
Journal:  Hand (N Y)       Date:  2007-07-25

9.  Diffusion Limited Cryopreservation of Tissue with Radiofrequency Heated Metal Forms.

Authors:  Zonghu Han; Anirudh Sharma; Zhe Gao; Timothy W Carlson; M Gerard O'Sullivan; Erik B Finger; John C Bischof
Journal:  Adv Healthc Mater       Date:  2020-09-02       Impact factor: 9.933

10.  Evaluation of cryopreserved donor skin viability: the experience of the regional tissue bank of Verona.

Authors:  Massimo Franchini; Daniela Zanini; Adelia Bosinelli; Silvia Fiorini; Sandra Rizzi; Chiara D'Aloja; Aurora Vassanelli; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.